GHK-Cu (100mg)

Description

GHK-Cu (100mg) is the bulk research quantity of copper tripeptide (Gly-His-Lys·Cu²⁺) — a naturally occurring human plasma copper-binding peptide first identified by Loren Pickart in 1973. The 100mg format supports extended multi-experiment protocols, dose-response studies across multiple fibroblast or keratinocyte models, or research programs requiring consistent batch supply across multiple timepoints.

Why Researchers Select GHK-Cu

GHK-Cu stimulates collagen synthesis, activates ECM-remodeling metalloproteinases, and provides antioxidant protection through copper sequestration. It has been studied in wound healing models, skin aging biology, and gene expression profiling where it demonstrates the ability to downregulate inflammatory genes while upregulating repair and remodeling pathways. The 100mg quantity is particularly suited for researchers running parallel studies across multiple cell lines or investigating concentration-dependent effects requiring a wide dosing range.

Common Research Applications

• Extended collagen synthesis and ECM remodeling studies
• Multi-arm wound healing mechanism research
• Anti-inflammatory gene expression profiling
• Copper-mediated antioxidant pathway studies

Molecular Profile

• MW: ~340.4 g/mol | CAS: 49557-75-7 | Purity: ≥98% HPLC

For Research Use Only. Not for human or veterinary use.